AU5221998A - Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors - Google Patents
Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitorsInfo
- Publication number
- AU5221998A AU5221998A AU52219/98A AU5221998A AU5221998A AU 5221998 A AU5221998 A AU 5221998A AU 52219/98 A AU52219/98 A AU 52219/98A AU 5221998 A AU5221998 A AU 5221998A AU 5221998 A AU5221998 A AU 5221998A
- Authority
- AU
- Australia
- Prior art keywords
- interleukin
- inhibitors
- potionally
- ketosteroids
- combination therapy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
- 229940046732 interleukin inhibitors Drugs 0.000 title 2
- 102000003814 Interleukin-10 Human genes 0.000 title 1
- 108090000174 Interleukin-10 Proteins 0.000 title 1
- 238000002648 combination therapy Methods 0.000 title 1
- 229940076144 interleukin-10 Drugs 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| WO700414 | 1997-04-17 | ||
| PCT/IB1997/000414 WO1997038695A1 (en) | 1996-04-17 | 1997-04-17 | Dhea combination therapy |
| PCT/EP1997/005716 WO1998047516A1 (en) | 1997-04-17 | 1997-10-16 | Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| AU5221998A true AU5221998A (en) | 1998-11-13 |
Family
ID=11004555
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AU52219/98A Abandoned AU5221998A (en) | 1997-04-17 | 1997-10-16 | Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors |
Country Status (2)
| Country | Link |
|---|---|
| AU (1) | AU5221998A (en) |
| WO (1) | WO1998047516A1 (en) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2356539A1 (en) * | 1998-11-24 | 2000-06-08 | Hollis-Eden Pharmaceuticals, Inc. | Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of malaria and the treatment of african and american trypanosomiasis |
| US6667299B1 (en) | 2000-03-16 | 2003-12-23 | Hollis-Eden Pharmaceuticals, Inc. | Pharmaceutical compositions and treatment methods |
| KR20010101074A (en) * | 1998-11-24 | 2001-11-14 | 추후제출 | Use of 17-ketosteroid compounds and derivatives, metabolites and precursors thereof in the treatment of hepatitis c virus and other togaviruses |
| AP2001002167A0 (en) * | 1998-11-27 | 2001-06-30 | Hollis Eden Pharmaceuticals | Use of 17-ketosteroids for the treatment of toxoplasmosis and crytosporidiosis |
| AU1579700A (en) * | 1998-12-15 | 2000-07-03 | Hollis-Eden Pharmaceuticals | Cytokine combination therapy |
| EP1444989A1 (en) | 2003-02-07 | 2004-08-11 | Giorgio Dr. Stassi | Sensitizing cells for apoptosis by selectively blocking cytokines |
| DE602005016402D1 (en) | 2004-05-24 | 2009-10-15 | Genvault Corp | STABLE STORAGE OF PROTEIN AND STABLE STORAGE OF NUCLEIC ACID IN RECYCLABLE FORM |
| US7553932B1 (en) | 2005-04-25 | 2009-06-30 | La Jolla Institute For Allergy And Immunology | Methods of treating viral infection with IL-10 receptor antagonists |
| US8283165B2 (en) | 2008-09-12 | 2012-10-09 | Genvault Corporation | Matrices and media for storage and stabilization of biomolecules |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3815472A1 (en) * | 1988-05-06 | 1989-11-16 | Centre Regional De Transfusion | MONOCLONAL ANTICOERPER AND ITS USE |
| IE882585L (en) * | 1988-08-25 | 1990-02-25 | Prendergast Patrick T | Viral treatment system |
| IL94878A (en) * | 1989-06-28 | 2003-01-12 | Schering Corp | Cytokine synthesis inhibitory factor, antagonists thereof and methods of using same |
| US5624823A (en) * | 1991-11-22 | 1997-04-29 | The General Hospital Corporation | DNA encoding procine interleukin-10 |
| TW243415B (en) * | 1992-08-20 | 1995-03-21 | Schering Corp | |
| WO1994008589A1 (en) * | 1992-10-09 | 1994-04-28 | The Board Of Trustees Of The Leland Stanford Junior University | Treatment of systemic lupus erythematosus with dehydroepiandrosterone |
| US5449688A (en) * | 1993-03-30 | 1995-09-12 | The United States Of America As Represented By The Department Of Health And Human Services | Method of treating chronic inflammatory diseases |
-
1997
- 1997-10-16 AU AU52219/98A patent/AU5221998A/en not_active Abandoned
- 1997-10-16 WO PCT/EP1997/005716 patent/WO1998047516A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| WO1998047516A1 (en) | 1998-10-29 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU4787697A (en) | Therapeutic gene | |
| IL205765A0 (en) | Mammalian cytokine: interleukin - b - 30 and isolated polunucleotides encoding the same | |
| GB9720148D0 (en) | Gene silencing materials and methods | |
| EP0796628A3 (en) | Inhaler | |
| AU1616499A (en) | Chemokine variants and methods of use | |
| AU3737297A (en) | Bacteriophage-mediated gene therapy | |
| AU5289698A (en) | Gas treatment devices | |
| HU9800574D0 (en) | Promoter of the cdc 25b gene, its preparation and use | |
| AU3432397A (en) | An alkylation catalyst and the application thereof | |
| AU6162198A (en) | An altered telomere repeat binding factor and therapeutic use thereof | |
| AU1769497A (en) | Modified cytokines for therapeutic use | |
| AU5221998A (en) | Combination therapy utilising 17-ketosteroids and interleukin inhibitors, or interleukin-10 potionally with interleukin inhibitors | |
| AU7333398A (en) | Nasal melatonin composition | |
| AU5031398A (en) | Gas treatment devices and systems | |
| AU9569998A (en) | Photo-spectrometers, methods of use and manufacture | |
| AU2677395A (en) | Furnaces and lining | |
| AU8396198A (en) | Axin gene and uses thereof | |
| AU4373197A (en) | Recombinant single chain antibodies directed against the gp54 cancer marker, composition comprising same and use thereof | |
| AU4209200A (en) | Gas cooktop and control system | |
| AU4571997A (en) | Resin-coated segment, and manufacture thereof | |
| AU3518695A (en) | Gene therapy for transplantation and inflammatory or thrmbotic conditions | |
| AU2529799A (en) | Benzofuran-4-carboxamides and their therapeutic use | |
| AU8148098A (en) | Laser-ignitable ignition composition and initiator devices and assemblies comprising the same | |
| AU1808699A (en) | Purified beta1,2-xylosyltransferase and uses thereof | |
| AU5496798A (en) | Human cc chemokine slc |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MK6 | Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase |